Exploring the links between systemic lupus erythematosus and cancer

Rheumatic Disease Clinics of North America

Volumn 31, Issue 2, 2005, Pages 387-402

  Bernatsky, Sasha ^a   Ramsey Goldman, Rosalind ^b   Clarke, Ann ^a  

^a MONTREAL GENERAL HOSPITAL   (Canada)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALKYLATING AGENT; AZATHIOPRINE; CYCLOPHOSPHAMIDE; ESTROGEN; IMMUNOSUPPRESSIVE AGENT; NONSTEROID ANTIINFLAMMATORY AGENT;

AGE DISTRIBUTION; BLADDER CANCER; BREAST CANCER; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER MORTALITY; CANCER PREVENTION; CANCER RISK; CANCER SCREENING; CANCER SUSCEPTIBILITY; CARCINOMA; CLINICAL FEATURE; COLORECTAL CANCER; CYSTITIS; DISEASE ASSOCIATION; DISEASE EXACERBATION; ENDOMETRIUM CANCER; EPSTEIN BARR VIRUS; ETHNIC DIFFERENCE; GENETIC RISK; GEOGRAPHIC DISTRIBUTION; GYNECOLOGIC CANCER; HEMATOLOGIC MALIGNANCY; HEMATURIA; HEPATITIS; HEPATOBILIARY SYSTEM CANCER; HIGH RISK PATIENT; HUMAN; LIFESTYLE; LIVER CANCER; LUNG CANCER; NONHODGKIN LYMPHOMA; NONHUMAN; OBESITY; OVARY CANCER; PRIORITY JOURNAL; PROGNOSIS; RACE DIFFERENCE; REVIEW; RISK ASSESSMENT; RISK REDUCTION; SEX DIFFERENCE; SJOEGREN SYNDROME; SMOKING; SYSTEMIC LUPUS ERYTHEMATOSUS; TREATMENT OUTCOME; UTERINE CERVIX CANCER; UTERINE CERVIX DYSPLASIA; VIRUS INFECTION; WART VIRUS;

HUMANS; IMMUNOSUPPRESSIVE AGENTS; LUPUS ERYTHEMATOSUS, SYSTEMIC; NEOPLASMS; RISK FACTORS;

EID: 19544378505     PISSN: 0889857X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rdc.2005.01.002     Document Type: Review

References (107)

1. K.A. Black, P.J. Zilko, and R.L. Dawkins Cancer in connective tissue disease Arthritis Rheum 25 1982 1130 1133
2. J.J. Canoso, and A.S. Cohen Malignancy in a series of 70 patients with systemic lupus erythematosus Arthritis Rheum 17 1974 383 390
3. M.L. Dupla, M. Khamashta, and V.P. Garcia Malignancy in SLE: a report of five cases in a series of 96 patients Lupus 2 1993 177 181
4. L. Bjornadal, B. Lovstrom, and I. Lundberg Patients with SLE have an increased cancer risk [abstract] Arthritis Rheum 43 2000 S165
5. L. Mellemkjaer, V. Andersen, and M.S. Linet Non-Hodgkin's lymphoma and other cancers among a cohort of patients with systemic lupus erythematosus Arthritis Rheum 40 1997 761 768
6. J. Cibere, J. Sibley, and M. Haga Systemic lupus erythematosus and the risk of malignancy Lupus 10 2001 394 400
7. T. Pettersson, E. Pukkala, and L. Teppo Increased risk of cancer in patients with systemic lupus erythematosus Ann Rheum Dis 51 1992 437 439
8. R. Ramsey-Goldman, S.A. Mattai, and E. Schilling Increased risk of malignancy in patients with systemic lupus erythematosus J Investigative Med 46 1998 217 222
9. R. Ramsey-Goldman, and A. Clarke Double trouble: are lupus and malignancy associated? Lupus 10 2001 388 391
10. S.M. Sultan, Y. Ioannou, and D.A. Isenberg Is there an association of malignancy with SLE? An analysis of 276 patients under long-term review Rheumatol 39 2000 1147 1152
11. D.M. Sweeney, S. Manzi, and J. Janosky Risk of malignancy in women with SLE J Rheumatol 22 1995 1478 1482
12. M. Abu-Shakra, D.D. Gladman, and M.B. Urowitz Malignancy in systemic lupus erythematosus Arthritis Rheum 39 1996 1050 1054
13. O. Nived, A. Bengtsson, and A. Jonsen Malignancies during follow-up in an epidemiologically defined SLE inception cohort in southern Sweden Lupus 10 2001 500 504
14. S. Bernatsky, R. Ramsey-Goldman, and J.-F. Boivin Cancer in systemic lupus erythematosus: an international multi-centre cohort study Arthritis Rheum 2005 in press
15. E.M. Tan, A.S. Cohen, and J.F. Fries The 1982 revised criteria for the classification of SLE Arthritis Rheum 25 1982 1271 1277
16. C. Stahl-Hallengren, A. Jonsen, O. Nived, and G. Sturfelt Incidence studies of systemic lupus erythematosus in Southern Sweden: increasing age, decreasing frequency of renal manifestations and good prognosis J Rheumatol 27 2000 685 691
17. L. Bjornadal, B. Lofstrom, and L. Yin Increased cancer incidence in a Swedish cohort of patients with systemic lupus erythematosus Scand J Rheumatol 31 2 2002 66 71
18. R. Fisher Overview of non-Hodgkin's lymphoma: biology, staging, and treatment Semin Oncol 30 2 2003 3 9
19. T. Pettersson, E. Pukkala, and L. Teppo Increased risk of cancer in patients with systemic lupus erythematosus Ann Rheum Dis 51 1992 437 439
20. L. Mellemkjaer, V. Andersen, and M.S. Linet Non-Hodgkin's lymphoma and other cancers among a cohort of patients with systemic lupus erythematosus Arthritis Rheum 40 4 1997 761 768
21. S. Bernatsky, R. Ramsey-Goldman, and R. Rajan Non-Hodgkin's lymphoma in systemic lupus erythematosus Arthritis Rheum 50 9 Suppl 2004 S1850
22. V.M. Benk, A. Al Herz, and D. Gladman Role of radiation therapy in patients with both a diagnosis of lupus and cancer Int J Radiation Oncol Biol Phys 57 2 Suppl 1 2003 S421 S422
23. M. Leung Analysis of a ten-year prospective cohort of multi-ethnic systemic lupus erythematosus patients-focusing on mortality, malignancy and organ damage [dissertation] 2001 Birmingham (UK) University of Birmingham
24. J. Dhar, D. Kmak, and R. Bhan Abnormal cervicovaginal cytology in women with lupus: a retrospective cohort study Gynecol Oncol 82 1 2001 4 6
25. Z. Blumenfeld, M. Lorber, and N. Yoffe Systemic lupus erythematosus: predisposition for uterine cervical dysplasia Lupus 3 1 1994 59 61
26. H. Bateman, Y. Yazici, and L. Leff Increased cervical dysplasia in intravenous cyclophosphamide-treated patients with SLE: a preliminary study Lupus 9 7 2000 542 544
27. G. Nyberg, O. Eriksson, and N. Westberg Increased incidence of cervical atypia in women with SLE treated with chemotherapy Arthritis Rheum 24 5 1981 648 650
28. L. Mellemkjaer, M.S. Linet, and G. Gridley Rheumatoid arthritis and cancer risk Eur J Cancer 32 10 1996 1753 1757
29. L.B. Signorello, W. Ye, and J.P. Fryzek Nationwide study of cancer risk among hip replacement patients in Sweden JNCI Cancer Spectrum 93 18 2001 1405 1410
30. P. Paavolainen, E. Pukkala, and P. Pulkkinen Cancer incidence in Finnish hip replacement patients from 1980 to 1995: a nationwide cohort study involving 31,651 patients [published erratum appears in J Arthroplasty 2000;15(1):136-7] J Arthroplasty 14 3 1999 272 280
31. J. Olsen, J. McLaughlin, and O. Nyren Hip and knee implantations among patients with osteoarthritis and risk of cancer: a record-linkage study from Denmark Int J Cancer 81 5 1999 719 722
32. A. Knight, J. Askling, and A. Ekbom Cancer incidence in a population-based cohort of patients with Wegener's granulomatosis Int J Cancer 100 1 2002 82 85
33. C. Talar-Williams, Y. Hijazi, and M. Walther Cyclophosphamide-induced cystitis and bladder cancer in patients with Wegener granulomatosis Ann Intern Med 124 5 1996 477 484
34. S. Bernatsky, A. Clarke, and R. Ramsey-Goldman Breast cancer stage at time of detection in women with systemic lupus erythematosus (SLE) Lupus 13 6 2004 469 472
35. K.E. Moss, Y. Ioannou, and S.M. Sultan Outcome of a cohort of 300 patients with systemic lupus erythematosus attending a dedicated clinic for over two decades Ann Rheum Dis 61 5 2002 409 413
36. H. Yoshitomo, H. Sachiko, and I. Akinori Susceptibility alleles for aberrant B-1 cell proliferation involved in spontaneously occurring B-cell chronic lymphocytic leukemia in a model of New Zealand white mice Blood 92 1998 3772 3779
37. S.E. Straus, E.S. Jaffe, and J.M. Puck The development of lymphomas in families with autoimmune lymphoproliferative syndrome with germline Fas mutations and defective lymphocyte apoptosis Blood 98 1 2001 194 200
38. E. Thomas, D. Brewster, and R. Black Risk of malignancy among patients with rheumatic conditions Int J Cancer 88 3 2000 497 502
39. A. Rosenthal, J. McLaughlin, and G. Gridley Incidence of cancer among patients with systemic sclerosis Cancer 76 5 1995 910 914
40. International Agency for Research on Cancer Facts and figures of cancer in the European community 1993 World Health Organization Lyon (France)
41. M.M. Ward, and S. Studenski Clinical prognostic factors in lupus nephritis. The importance of hypertension and smoking Arch Intern Med 152 1992 2082 2088
42. M. Petri, S. Perez-Gutthann, and D. Spence Risk factors for coronary artery disease in patients with SLE Am J Med 93 1992 513 519
43. P. Rahman, M.B. Urowitz, and D.D. Gladman Contribution of traditional risk factors to coronary artery disease in patients with SLE J Rheumatol 26 1999 2363 2368
44. T. McAlindon, L. Giannotta, and N. Taub Environmental factors predicting nephritis in systemic lupus erythematosus Ann Rheum Dis 52 1993 720 724
45. I.N. Bruce, D.D. Gladman, and M.B. Urowitz Detection and modification of risk factors for coronary artery disease in patients with systemic lupus erythematosus: a quality improvement study Clin Exp Rheumatol 16 1998 435 440
46. I.N. Bruce, M.B. Urowitz, and D.D. Gladman Risk factors for coronary heart disease in women with systemic lupus erythematosus: the Toronto Risk Factor Study G Arthritis Rheum 48 11 2003 3159 3167
47. S. Bernatsky, J. Boivin, and L. Joseph The prevalence of factors influencing cancer risk in lupus: social habits reproductive issues and obesity J Rheumatol 29 12 2002 2551 2554
48. L. Garfinkel Overweight and cancer Ann Intern Med 103 1985 1034 1036
49. H. Moller, A. Mellemgaard, and K. Lindvig Obesity and cancer risk: a Danish record-linkage study Eur J Cancer 30A 3 1994 344 350
50. J. Austoker Diet and cancer BMJ 308 1994 1610 1614
51. F. Levi, C. La Vecchia, and E. Negri Body mass at different ages and subsequent endometrial cancer risk Int J Cancer 50 1992 567 571
52. B.A. Reeder, A. Angel, and M. Ledoux Obesity and its relation to cardiovascular disease risk factors in Canadian adults. Canadian Heart Health Surveys Research Group CMAJ 146 1992 2009 2019
53. P. Cras, C. Franckx, and J. Martin Primary intracerebral lymphoma in systemic lupus erythematosus treated with immunosuppressives Clin Neuropathol 8 1989 200 205
54. M.E. Hehir, J.R. Sewell, and G.R.V. Hughes Reticulum cell sarcoma in azathioprine-treated systemic lupus erythematosus Ann Rheum Dis 38 1979 94 95
55. R.W. Elliott, D.M. Essenhigh, and A.R. Morley Cyclophosphamide treatment of systemic lupus erythematous: risk of bladder cancer exceeds benefits BMJ 284 1982 1160 1161
56. A.M. Ortiz, E. Gonzalez-Parra, and G. Alvarez-Costa Bladder cancer after cyclophosphamide therapy for lupus nephritis Nephron 60 1992 378 379
57. J.B. Thrasher, G.J. Miller, and J.N. Wettlaufer Bladder leiomyosarcoma following cyclophosphamide therapy for lupus nephritis J Urol 143 1990 119 121
58. T.P. Casey Azathioprine (Imuran) administration and the development of malignant lymphoma in NZB mice Clin Exp Immunol 3 1968 305 312
59. L. Kyllonen, K. Salmela, and E. Pukkala Cancer incidence in a kidney-transplanted population Transpl Int 13 Suppl 1 2000 S394 S398
60. G. Opelz, and R. Henderson Incidence of non-Hodgkin lymphoma in kidney and heart transplant recipients Lancet 342 8886-7 1993 1514 1516
61. H. Nossent, and W. Koldingsnes Long-term efficacy of azathioprine treatment for proliferative lupus nephritis Rheumatol 39 9 2000 969 978
62. F. Martin, B. Lauwerys, and C. Lefebvre Side-effects of intravenous cyclophosphamide pulse therapy Lupus 6 3 1997 254 257
63. H.M. Belmont, M. Storch, and J. Buyon New York University/Hospital for Joint Diseases experience with intravenous cyclophosphamide treatment Lupus 4 2 1997 104 108
64. D.T. Boumpas, H.A. Austin 3rd, and E.M. Vaughan Severe lupus nephritis: controlled trial of pulse methylprednisone versus two different regiments of pulse cyclophosphamide Lancet 340 1992 741 744
65. H. Austin, J. Klippel, and J. Balow Therapy of lupus nephritis. Controlled trial of prednisone and cytotoxic drugs N Engl J Med 314 10 1986 614 619
66. P. Asten, J. Barrett, and D. Symmons Risk of developing certain malignancies is related to duration of immunosuppressive drug exposure in patients with rheumatic diseases J Rheumatol 26 8 1999 1705 1714
67. C. Williams, W. Smalley, and R. DuBois Aspirin use and potential mechanisms for colorectal cancer prevention J Clin Invest 100 6 1997 1325 1329
68. J. Baron, and R. Sandler Nonsteroidal anti-inflammatory drugs and cancer prevention Annu Rev Pharmacol Toxicol 51 2000 511 523
69. L.A. Garcia-Rodriguez, and C. Huerta-Alvarez Reduced risk of colorectal cancer among long-term users of aspirin and nonaspirin nonsteroidal antiinflammatory drugs Epidemiology 12 2001 88 93
70. L. Perron, I. Bairati, and L. Moore Dosage, duration and timing of nonsteroidal antiinflammatory drug use and risk of prostate cancer Int J Cancer 106 3 2003 409 415
71. G. Cooper, M. Dooley, and E. Treadwell Hormonal and reproductive risk factors for development of systemic lupus erythematosus: results of a population-based, case-control study Arthritis Rheum 46 7 2004 1830 1839
72. C.C. Mok, C.S. Lau, and C.T. Ho Safety of hormonal replacement therapy in postmenopausal patients with systemic lupus erythematosus Scand J Rheumatol 27 1998 342 346
73. W. Xu, Y. Xiang, and Z. Ruan Menstrual and reproductive factors and endometrial cancer risk: results from a population-based case-control study in urban Shanghai Int J Cancer 108 4 2004 613 619
74. S.A.A. Beresford, N.S. Weiss, and L.F. Voigt Risk of endometrial cancer in relation to use of oestrogen combined with cyclic progestagen therapy in postmenopausal women Lancet 349 1997 458 461
75. M.C. Pike, R.K. Peters, and W. Cozen Estrogen-progestin replacement therapy and endometrial cancer J Natl Cancer Inst 89 1997 1110 1116
76. K. Takada, G. Illei, and D. Boumpas Cyclophosphamide for the treatment of systemic lupus erythematosus Lupus 10 3 2001 154 162
77. M. Abu-Shakra, M. Ehrenfeld, and Y. Shoenfeld Systemic lupus erythematosus and cancer: associated or not? Lupus 11 3 2002 137 144
78. S. Bernatsky, A. Clarke, and R. Ramsey-Goldman Malignancy and systemic lupus erythematosus Curr Rheumatol Rep 4 4 2002 351 358
79. M. Ehrenfeld, M. Abu-Shakra, and D. Buskila The dual association between lymphoma and autoimmunity Blood Cells Mol Dis 27 4 2001 750 756
80. O. Trejo, M. Ramos-Casals, and A. Lopez-Guillermo Hematologic malignancies in patients with cryoglobulinemia: association with autoimmune and chronic viral diseases Semin Arthritis Rheum 33 1 2003 19 28
81. M.P. Pender Infection of autoreactive B lymphocytes with EBV, causing chronic autoimmune diseases Trends Immunol 24 2003 584 588
82. M. Hummel, I. Anagnostopoulos, and P. Korbjuhn Epstein-Barr virus in B-cell non-Hodgkin's lymphomas: unexpected infection patterns and different infection incidence in low-and high-grade types J Pathol 175 1995 263 271
83. R.F. Jarrett, and J. MacKenzie Epstein-Barr virus and other candidate viruses in the pathogenesis of Hodgkin's disease Semin Hematol 36 3 1999 260 269
84. M.H. Schiffman, H.M. Bauer, and R.N. Hoover Epidemiological evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia J Natl Can Inst 1993 1993 958 964
85. S. Berthier, C. Mougin, and P. Vercherin Does a particular risk associated with papillomavirus infections exist in women with lupus? Rev Med Interne 20 2 1999 128 132
86. J. Kigawa, Y. Kanamori, and Y. Takeuchi Involvement of the local immune response in a case of advanced cervical cancer in a patient with systemic lupus erythematosus Gynecol Obstet Invest 36 1 1993 62 64
87. T.E. McCurley, R.D. Collins, and E. Ball Nodal and extranodal lymphoproliferative disorders in Sjögren's syndrome: a clinical and immunopathological study Hum Pathol 21 1990 482 492
88. G. Valesini, R. Priori, and D. Bavoillot Differential risk of non-Hodgkin's lymphoma in Italian patients with primary Sjogren's syndrome J Rheumatol 24 12 1997 2376 2380
89. J. Ioannidis, V. Vassiliou, and H. Moutsopoulos Long-term risk of mortality and lymphoproliferative disease and predictive classification of primary Sjogren's syndrome Arthritis Rheum 46 3 2002 741 747
90. E. Baecklund, C. Sundstrom, and A. Ekbom Lymphoma subtypes in patients with rheumatoid arthritis-increased proportion of diffuse large B cell lymphoma Arthritis Rheum 48 6 2003 1543 1550
91. J. Pope Scleroderma overlap syndromes Curr Opin Rheumatol 14 6 2002 704 710
92. C.L. Hill, A.M. Nguyen, and D. Roder Risk of cancer in patients with scleroderma: a population based cohort study Ann Rheum Dis 62 8 2003 728 731
93. J.E. Pearson, and A.J. Silman Risk of cancer in patients with scleroderma Ann Rheum Dis 62 8 2003 697 699
94. J. Findor, X.S. He, and J. Sord Primary biliary cirrhosis and hepatocellular carcinoma Autoimmun Rev 1 4 2002 220 225
95. S. Abraham, S. Begum, and D. Isenberg Hepatic manifestations of autoimmune rheumatic diseases Ann Rheum Dis 63 2 2004 123 129
96. D. Parkin S. Whelan J. Ferlay Cancer incidence in five continents, vol. VI. IARC Scientific Publication no. 143 1997 International Agency for Research on Cancer Lyon (France)
97. S. Landis, T. Murray, and S. Bolden Cancer statistics, 1999 CA Cancer J Clin 49 1 1999 8 31
98. D. Henson, K. Chu, and P. Levine Histologic grade, stage, and survival in breast carcinoma: comparison of African American and Caucasian women Cancer 98 5 2003 908 917
99. S. Bernatsky, R. Ramsey-Goldman, and J.-.F. Boivin Racial factors relating to cancer occurrence in systemic lupus [Abstract] Arthritis Rheum 9 Suppl 2003 S1821
100. J. Izquierdo, and V.J. Schoenbach The potential & limitations of data from population-based state cancer registries Am J Public Health 90 2000 695 698
101. D. Brewster, J. Crichton, and C. Muir How accurate are Scottish cancer registration data? Br J Cancer 70 1994 954 959
102. N.S. Rawson, and D.L. Robson Concordance on the recording of cancer in the Saskatchewan Cancer Agency Registry, hospital charts and death registrations Can J Public Health 91 2000 390 393
103. A.J. Swerdlow, A.J. Douglas, H.G. Vaughan, and H.B. Vaughan Completeness of cancer registration in England and Wales Br J Cancer 67 1993 326 329
104. A. Freedman, and L. Nadler Non-Hodgkin's lymphomas R. Bast W. Kufe R. Pollock Cancer medicine. Section 134 2000 BC Decker Inc Hamilton (Canada)
105. K.E. Bowles, C. Wynne, and M.J. Baime Screening for cancer in the patient with rheumatic disease Rheum Dis Clin North Am 25 3 1999 719 744
106. C. Talar-Williams, Y.M. Hijazi, and M.M. Walther Cyclophosphamide-induced cystitis and bladder cancer in patients with wegener granulomatosis Ann Intern Med 124 5 1996 477 484
107. ACOG Committee on practice bulletins ACOG Practice Bulletin: clinical management guidelines for obstetrician-gynecologists. Number 45, August 2003. Cervical cytology screening (replaces committee opinion 152, March 1995) Obstet Gynecol 102 2 2003 417 427